Helixgate

Helixgate

Uncategorized

The U.S. infant mortality rate fell to an all-time low, though it still trails other similar nations

NEW YORK — Infant mortality in the U.S. dropped to a new all-time low in 2025, according to preliminary government data.

There were slightly fewer than 5.4 infant deaths per 1,000 live births in 2025, according to the Centers for Disease Control and Prevention.

Read the rest…

Read More

Published

on

NEW YORK — Infant mortality in the U.S. dropped to a new all-time low in 2025, according to preliminary government data.

There were slightly fewer than 5.4 infant deaths per 1,000 live births in 2025, according to the Centers for Disease Control and Prevention.

Read the rest…

Read More

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Uncategorized

Be Bio bins hemophilia B cell therapy trial—the biotech’s lead program

Published

on

Be Biopharma’s terminated trial is the latest setback in the hemophilia space, where companies like Pfizer and BioMarin have opted to pull their respective products from the market after weak traction.

Continue Reading

Uncategorized

STAT+: Is Abridge’s ‘patient centered’ claim a bridge too far?

You’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence in health care and medicine. Sign up to get it delivered in your inbox every Wednesday. 

I cried reading about people’s shared moments with strangers at the bottom of last week’s edition of “We’re Here,” the community newsletter from Hank and John Green.

My colleague Eric Boodman’s stories usually make me cry as well, but his recent article about babies being born with congenital syphilis, which is usually totally preventable with penicillin from Pfizer, made me want to tear my hair out.

Continue to STAT+ to read the full story…

Read More

Published

on

You’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence in health care and medicine. Sign up to get it delivered in your inbox every Wednesday. 

I cried reading about people’s shared moments with strangers at the bottom of last week’s edition of “We’re Here,” the community newsletter from Hank and John Green.

My colleague Eric Boodman’s stories usually make me cry as well, but his recent article about babies being born with congenital syphilis, which is usually totally preventable with penicillin from Pfizer, made me want to tear my hair out.

Continue to STAT+ to read the full story…

Read More

Continue Reading

Uncategorized

Edgewise slides as cardiomyopathy challenger to BMS, Cytokinetics falls short

Published

on

Although Edgewise Therapeutics’ hypertrophic cardiomyopathy asset missed expectations, Truist Securities called the data “excellent,” leaning on a safety profile that could eliminate the need for risk evaluation and mitigation strategies.

Continue Reading
Advertisement

Trending